(GSK) Glaxosmithkline Plc complete technical analysis [charts+indicators] | Buy/Sell Glaxosmithkline Plc | (GSK) share price targets
Complete technical analysis of Glaxosmithkline Plc (GSK) by charts plus indicators, forecast predictions and share price targets for Glaxosmithkline Plc (GSK)
Glaxosmithkline Plc trades in USA in Health Care sector.
Showing technical analysis as on 2025-03-21 View latest technical analysis
10 day averaged volume of Glaxosmithkline Plc is 5200090
Date | Daily Closing Price | Open | High | Low | Volume |
21 Fri Mar 2025 | 39.24 | 39.29 | 39.50 | 39.14 | 0.773 times |
20 Thu Mar 2025 | 39.41 | 39.58 | 39.66 | 39.24 | 0.643 times |
19 Wed Mar 2025 | 39.55 | 39.55 | 39.80 | 39.27 | 0.85 times |
18 Tue Mar 2025 | 40.39 | 40.23 | 40.39 | 40.11 | 0.703 times |
17 Mon Mar 2025 | 40.25 | 39.88 | 40.47 | 39.85 | 0.8 times |
14 Fri Mar 2025 | 39.49 | 39.21 | 39.61 | 39.05 | 0.95 times |
13 Thu Mar 2025 | 39.23 | 39.02 | 39.39 | 38.93 | 0.757 times |
12 Wed Mar 2025 | 38.88 | 39.32 | 39.32 | 38.78 | 1.077 times |
11 Tue Mar 2025 | 39.50 | 40.12 | 40.12 | 39.33 | 1.157 times |
10 Mon Mar 2025 | 40.32 | 40.37 | 40.81 | 40.10 | 1.5 times |
My analysis of stock is bullish for shortterm, and stock might move up till 39.9 or till 41.2. Use a stoploss of 38.93 and if this stock hits its stoploss, then it can fall down till 37.92
Share price targets for Glaxosmithkline Plc (GSK)
Target Type | Value |
Downside Target | 31.72 |
Downside Target | 32.83 |
Downside Target | 34.22 |
Downside Target | 35.59 |
Downside Target | 38.40 |
Downside Target | 38.78 |
Downside Target | 39.14 |
Upside Target | 40.47 |
Upside Target | 40.59 |
Upside Target | 40.81 |
Intraday share price targets for Glaxosmithkline Plc (GSK)
Target Type | Value |
Downside Intraday Target | 38.76 |
Downside Intraday Target | 38.29 |
Upside Intraday Target | 40.09 |
Upside Intraday Target | 40.95 |
Upside Intraday Target | 39.62 |
Weekly technical analysis of Glaxosmithkline Plc (GSK)
Date | Weekly Closing Price | Open | High | Low | Volume |
21 Fri Mar 2025 | 39.24 | 39.88 | 40.47 | 39.14 | 0.693 times |
14 Fri Mar 2025 | 39.49 | 40.37 | 40.81 | 38.78 | 1.052 times |
07 Fri Mar 2025 | 40.05 | 38.17 | 40.59 | 37.77 | 0.779 times |
28 Fri Feb 2025 | 37.59 | 36.82 | 38.40 | 36.72 | 1.757 times |
21 Fri Feb 2025 | 36.64 | 36.59 | 37.22 | 36.05 | 0.892 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Glaxosmithkline Plc (GSK)
Date | Monthly Closing Price | Open | High | Low | Volume |
21 Fri Mar 2025 | 39.24 | 38.17 | 40.81 | 37.77 | 0.684 times |
28 Fri Feb 2025 | 37.59 | 34.87 | 38.40 | 34.22 | 1.21 times |
31 Fri Jan 2025 | 35.27 | 33.94 | 35.59 | 31.72 | 1.39 times |
31 Tue Dec 2024 | 33.82 | 34.70 | 36.28 | 33.04 | 0.447 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Glaxosmithkline Plc (GSK)
Price action analysis of Glaxosmithkline Plc ( (GSK) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Glaxosmithkline Plc ( (GSK) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Glaxosmithkline Plc ( (GSK) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Glaxosmithkline Plc ( (GSK) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Glaxosmithkline Plc stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Glaxosmithkline Plc in short term but the sell signal is initial and weak.
Glaxosmithkline Plc Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Glaxosmithkline Plc in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Glaxosmithkline Plc is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 39.65 and Glaxosmithkline Plc (GSK) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Glaxosmithkline Plc (GSK) stock. Volume based technical analysis of Glaxosmithkline Plc (GSK) stock is negative.
Glaxosmithkline Plc Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Glaxosmithkline Plc ( (GSK) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Glaxosmithkline Plc ( (GSK) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Glaxosmithkline Plc ( (GSK) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Glaxosmithkline Plc ( (GSK) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Glaxosmithkline Plc stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Glaxosmithkline Plc in short term but the sell signal is initial and weak.
Glaxosmithkline Plc Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Glaxosmithkline Plc in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Glaxosmithkline Plc is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 39.65 and Glaxosmithkline Plc (GSK) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Glaxosmithkline Plc (GSK) stock. Volume based technical analysis of Glaxosmithkline Plc (GSK) stock is negative.
Glaxosmithkline Plc Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.